Walgreens coughs up nearly $6 mil. to settle with FTC
This article was originally published in The Tan Sheet
Executive Summary
Walgreens will pay nearly $6 million to settle charges with the Federal Trade Commission that the pharmacy chain deceptively advertised Wal-Born, a supplement similar to Airborne cold-and-flu products, the FTC said in a March 23 release. FTC says Walgreens advertised the product in newspaper circulars and online with " baseless claims" the supplements could prevent colds, fight germs and boost the immune system. Further, a federal court approved a settlement of $565,000 for Wal-Born manufacturer Improvita Health Products' two principal officers. FTC says Walgreens sold the supplements and marketed them with their similarities to Airborne, which FTC charged with deceptive advertising and settled in 2008 (1"The Tan Sheet" April 18, 2008). FTC's suit against Improvita is still being litigated. Improvita manufactured similar store-brand products for Rite Aid, which the FTC settled cases with in 2009
You may also be interested in...
FTC Settlement Looks To Ground Airborne Claims
Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.